We then performed gene ontology (GO) analysis on the differentially methylated enhancers and found significant enrichment in signaling pathways commonly affected in liver cancer, including regulation of RAC1 activity (29) and interleukin-8 (IL-8)– and CXCR1-mediated signaling (fig. The gene discussed is CXCR1; the disease is liver cancer.